𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington’s disease

✍ Scribed by Dénes Zádori; Gábor Nyiri; András Szőnyi; István Szatmári; Ferenc Fülöp; József Toldi; Tamás F. Freund; László Vécsei; Péter Klivényi

Publisher
Springer
Year
2010
Tongue
English
Weight
583 KB
Volume
118
Category
Article
ISSN
1435-1463

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Riluzole prolongs survival time and alte
Riluzole prolongs survival time and alters nuclear inclusion formation in a transgenic mouse model of Huntington's disease
✍ Johannes Schiefer; G. Bernhard Landwehrmeyer; Hans-Gerd Lüesse; Arne Sprünken; C 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 375 KB

Glutamate excitotoxicity has been suggested to contribute to the pathogenesis of Huntington's disease (HD). Riluzole is a substance with glutamate antagonistic properties that is used for neuroprotective treatment in amyotrophic lateral sclerosis and which is currently tested in clinical trials for

Erythropoietin is neuroprotective in a t
Erythropoietin is neuroprotective in a transgenic mouse model of multiple system atrophy
✍ Martin Köllensperger; Florian Krismer; Anton Pallua; Nadia Stefanova; Werner Poe 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 441 KB

## Abstract Multiple system atrophy is a rapidly progressive neurodegenerative disorder with a markedly reduced life expectancy. Failure of symptomatic treatment raises an urgent need for disease‐modifying strategies. We have investigated the neuroprotective potential of erythropoietin in (proteoli